J4 ›› 2010, Vol. 36 ›› Issue (3): 543-545.

• 临床研究 • 上一篇    下一篇

血清人附睾蛋白4的检测及其在卵巢癌诊断中的意义

 欧健, 张晓霞, 王翠翠, 王丽娜   

  1. (吉林大学第一医院妇产科|吉林 长春 130021
  • 收稿日期:2009-07-22 出版日期:2010-05-28 发布日期:2010-05-28
  • 通讯作者: 张晓霞 E-mail:zhangxx626@yahoo.com.cn
  • 作者简介:欧 健(1985-)|女|内蒙古自治区乌兰浩特市人|在读医学硕士|主要从事卵巢癌诊断研究。
  • 基金资助:

    吉林省科技厅科研基金资助课题(200705155);吉林省教育厅基金资助课题(吉教科合字[2005]第132号)


Detection of |serum |human epididymis protein 4 |and its significance in |diagnosis of |ovarian cancer

 OU Jian, ZHANG Xiao-Xia, WANG Cui-Cui, WANG Li-Na   

  1. (Department of |Obstetrics and Gynecology,First Hospital,Jilin University,Changchun 130021,China)
  • Received:2009-07-22 Online:2010-05-28 Published:2010-05-28

摘要:

目的: 检测卵巢癌患者血清人附睾蛋白4(HE4)水平,探讨血清HE4在卵巢癌诊断中的意义。方法:应用 ELISA法检测卵巢癌组、卵巢良性肿瘤组、妇科其他恶性肿瘤组、其他器官恶性肿瘤组患者血清HE4水平;观察卵巢癌组手术前、后血清HE4水平变化;比较卵巢癌组血清HE4和CA125水平在卵巢癌诊断中的作用。结果:卵巢癌组血清HE4水平和阳性率分别为(242.76±113.40)pmol.L-1和70.59%,明显高于卵巢良性肿瘤组[(85.57±63.40)pmol.L-1和7.02%]、妇科其他恶性肿瘤组[(73.16±12.27)pmol?L-1和0.00%]、其他器官恶性肿瘤组[(80.65±16.24)pmol.L-1和0.00%]及对照组[(43.95±18.16)pmol?L-1和0.00%](P<0.01);卵巢癌组术后血清HE4水平为(134.83±56.20)pmol.L-1,显著低于手术前HE4水平(242.76±113.40)pmol.L-1(P<0.05);早期卵巢癌血清HE4阳性率高于血清CA125阳性率;卵巢癌组血清HE4和CA125联合检测的灵敏性高于二者单独检测,特异性低于二者的单独检测(P<0.05)。结论:HE4在卵巢癌诊断中有重要意义,尤其在早期卵巢癌的诊断中其灵敏度及特异性均优于CA125,二者联合检测可提高卵巢癌的早期诊断率。

关键词: 人附睾蛋白4;CA125;卵巢肿瘤;酶联免疫法

Abstract:

Abstract:Objective
To detect the level of serum  human epididymis protein 4(HE4) in the  patients  with ovarian cancer and approach the significance of serum  HE4  in the diagnosis
of  ovarian cancer.Methods ELISA mothod was used to detect the levels of serum  HE4   in  ovarian cancer group,benign ovarian tumor group,other malignant gynecology tumor group and malignant tumor of other organs group.The changes of the serum HE4 level   in ovarian cancer group before and  after operation were detected.The effects of  the serum HE4 level and CA215 level  in  ovarian cancer group    in the diagnois of  ovarian cancer were compared.Results The serum  HE4 levels ovarian cancer group was (242.76±113.40)pmol.L-1 and the positive rate was 70.59%,they were higher than those in  benign ovarian tumor group(85.57 pmol.L-1±63.40 pmol.L-1,7.02%),other malignant gynecology tumor group (73.16 pmol.L-1±12.27 pmol.L-1,0.00%),malignant tumor of other organs group(80.65 pmol?L-1±16.24 pmol.L-1,0.00%)and control group(43.95 pmol.L-1±18.16 pmol?L-1,0.00%)(P<0.01);the serum HE4 level in  ovarian cancer group after operation(134.83 pmol.L-1±56.20 pmol?L-1) was lower than  before operation(242.76 pmol.L-1±113.40 pmol.L-1)(P<0.05).The positive  rate of serum HE4  in the early  ovarian cancer  was higher than that of seum CA125.The sensitiveity of HE4 combined with CA125 was  higher  than each of them,the specificity of HE4 combined with CA125 was  lower than each of them(P<0.05).Conclusion The HE4 serum has important significance in the diagnosis of  ovarian cancer,especially,its sensitivity and specificity are all better than CA125 in the diagnosis of  early  ovarian cancer,the detection of  HE4 combined with CA125 can elevate the early diagnosis rate of  ovarian cancer.

Key words: human epididymis protein 4;CA125;ovarian neoplasms;euzyme linked immunosorbent assay

中图分类号: 

  • R737.31